1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Physciosporin suppresses the proliferation, motility and tumourigenesis of colorectal cancer cells
(
- Contribution to journal › Article
-
Mark
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer
(
- Contribution to journal › Article
-
Mark
ABCC3 is a novel target for the treatment of pancreatic cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Acetonic extracts of the endolichenic fungus EL002332 isolated from Endocarpon pusillum exhibits anticancer activity in human gastric cancer cells
(
- Contribution to journal › Article
- 2015
-
Mark
Adaptive mitochondrial reprogramming and resistance to PI3K therapy
(
- Contribution to journal › Article
- 2014
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842(
- Contribution to journal › Article
- 2012
-
Mark
Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K
(
- Contribution to journal › Article
-
Mark
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
(
- Contribution to journal › Article
- 2011
-
Mark
Stem cell gene expression programs influence clinical outcome in human leukemia
(
- Contribution to journal › Article
- 2010
-
Mark
Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells
(
- Contribution to journal › Article